Australian Leukemia Study Aims to End Lifelong Treatment

A groundbreaking five-year research program could help two-thirds of chronic myeloid leukemia patients stop treatment forever instead of taking daily medication for life.

Scientists are now focused on understanding why some patients can safely quit therapy while others cannot.